These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18220505)

  • 41. SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs.
    Zhang F; Lee KB; Linhardt RJ
    Biosensors (Basel); 2015 Jul; 5(3):500-12. PubMed ID: 26213979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A perspective on the primary and three-dimensional structures of carbohydrates.
    Widmalm G
    Carbohydr Res; 2013 Aug; 378():123-32. PubMed ID: 23522728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recognition roles of mammalian structural units and polyvalency in lectin--glycan interactions.
    Wu AM; Liu JH; Singh T; Yang Z
    Adv Exp Med Biol; 2011; 705():99-116. PubMed ID: 21618106
    [No Abstract]   [Full Text] [Related]  

  • 44. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.
    Fermas S; Gonnet F; Sutton A; Charnaux N; Mulloy B; Du Y; Baleux F; Daniel R
    Glycobiology; 2008 Dec; 18(12):1054-64. PubMed ID: 18796646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conformational dynamics of oligosaccharides characterized by paramagnetism-assisted NMR spectroscopy in conjunction with molecular dynamics simulation.
    Zhang Y; Yamaguchi T; Satoh T; Yagi-Utsumi M; Kamiya Y; Sakae Y; Okamoto Y; Kato K
    Adv Exp Med Biol; 2015; 842():217-30. PubMed ID: 25408346
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan.
    Sommer A; Rifkin DB
    J Cell Physiol; 1989 Jan; 138(1):215-20. PubMed ID: 2910884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycoconjugates: overview and strategy.
    Laine RA
    Methods Enzymol; 1990; 193():539-53. PubMed ID: 2074835
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of lectins in analysis of glycoconjugates.
    Cummings RD
    Methods Enzymol; 1994; 230():66-86. PubMed ID: 8139516
    [No Abstract]   [Full Text] [Related]  

  • 49. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulfotransferases and sulfated oligosaccharides.
    Honke K; Taniguchi N
    Med Res Rev; 2002 Nov; 22(6):637-54. PubMed ID: 12369092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recent advance in carbohydrate-based cancer vaccines].
    Huo CX; Ye XS
    Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The five bacterial lectins (PA-IL, PA-IIL, RSL, RS-IIL, and CV-IIL): interactions with diverse animal cells and glycoproteins.
    Gilboa-Garber N; Zinger-Yosovich KD; Sudakevitz D; Lerrer B; Imberty A; Wimmerova M; Wu AM; Garber NC
    Adv Exp Med Biol; 2011; 705():155-211. PubMed ID: 21618109
    [No Abstract]   [Full Text] [Related]  

  • 53. Structural Analysis of Oligosaccharides and Glycoconjugates Using NMR.
    Yamaguchi Y; Yamaguchi T; Kato K
    Adv Neurobiol; 2023; 29():163-184. PubMed ID: 36255675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paradigms in the structural biology of the mitogenic ternary complex FGF:FGFR:heparin.
    Pomin VH
    Biochimie; 2016 Aug; 127():214-26. PubMed ID: 27263122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides.
    Chuang WL; Christ MD; Peng J; Rabenstein DL
    Biochemistry; 2000 Apr; 39(13):3542-55. PubMed ID: 10736153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enabling methodology for the end functionalization of glycosaminoglycan oligosaccharides.
    Gemma E; Meyer O; Uhrín D; Hulme AN
    Mol Biosyst; 2008 Jun; 4(6):481-95. PubMed ID: 18493641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells.
    Bârzu T; Lormeau JC; Petitou M; Michelson S; Choay J
    J Cell Physiol; 1989 Sep; 140(3):538-48. PubMed ID: 2550475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The activation of fibroblast growth factors (FGFs) by glycosaminoglycans: influence of the sulfation pattern on the biological activity of FGF-1.
    Angulo J; Ojeda R; de Paz JL; Lucas R; Nieto PM; Lozano RM; Redondo-Horcajo M; Giménez-Gallego G; Martín-Lomas M
    Chembiochem; 2004 Jan; 5(1):55-61. PubMed ID: 14695513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conformational studies of oligosaccharides, polysaccharides and glycoconjugates. Papers from an international workshop. Le Croisic, France, 29 June-2 July, 1992.
    Int J Biol Macromol; 1993 Feb; 15(1):1-72. PubMed ID: 8095155
    [No Abstract]   [Full Text] [Related]  

  • 60. 3D structure of a heparin mimetic analogue of a FGF-1 activator. A NMR and molecular modelling study.
    Muñoz-García JC; Solera C; Carrero P; de Paz JL; Angulo J; Nieto PM
    Org Biomol Chem; 2013 Dec; 11(47):8269-75. PubMed ID: 24178304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.